Mevalonate-regulated mechanisms in cell growth control: Role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc

Glycobiology

Volumn 7, Issue 5, 1997, Pages 625-633

  Dricu, Anica ^a   Wang, Min ^a   Hjertman, Magnus ^a   Malec, Maria ^a   Blegen, Harald ^a   Wejde, Johan ^a   Carlberg, Magdalena ^a   Larsson, Olle ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

c myc; Dolichyl phosphate; IGF 1 receptor; N linked glycosylation; Ras

Indexed keywords

DOLICHOL PHOSPHATE; MEVALONIC ACID; MEVINOLIN; MYC PROTEIN; RAS PROTEIN; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GLYCOPROTEIN SYNTHESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL DIVISION; CELL MEMBRANE; COLONIC NEOPLASMS; DNA, NEOPLASM; DOLICHOL PHOSPHATES; GLYCOSYLATION; HUMANS; KINETICS; LOVASTATIN; MELANOMA; MEVALONIC ACID; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN ISOPRENYLATION; RAS PROTEINS; RECEPTOR, IGF TYPE 1; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030808048     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/7.5.625     Document Type: Article

References (44)

1. Adair, W.L. and Keller, R.K. (1985) Isolation and assay of dolichol and dolichyl-phosphate. Methods Enzymol., 111, 201-215.
2. Barbu, V. and Dautry, F. (1990) Mevalonate deprivation alters the induction of fos and myc by growth factors. Oncogene, 5, 1077-1080.
3. Bhat, N.R. and Waechter, C.J. (1988) Induction of N-linked glycosylation activity in cultured embryonic rat brain cells. J. Neurochem., 50, 375-381.
4. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
5. Brown, M.S. and Goldstein, J.L. (1980) Multivalent feedback regulation of HMG-CoA reductase: a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res., 21, 505-517.
6. Brown, M.S. and Goldstein, J.L. (1994) Protein prenylation. Mad bet for rap. Nature, 366, 14-15.
7. Carlberg, M. and Larsson, O. (1996) Stimulatory effect of PDGF on HMG-CoA reductase activity and N-linked glycosylation contributes to the increased expression of IGF-1 receptors in human fibroblasts. Exp. Cell Res., 223, 142-148.
8. Carlberg, M., Hjertman, M., Wejde, J. and Larsson, O. (1994). Mevalonate is essential for growth activation of human fibroblasts: Evidence for a critical role of protein glycosylation in the prereplicative period. Exp. Cell Res., 212, 359-366.
9. Carlberg, M., Dricu, A., Blegen, H., Wang, M., Hjertman, M., Zickert, P., Höög, A. and Larsson, O. (1996) Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface: evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cell growth. J. Biol. Chem., 271, 17453-17462.
10. Clemmons, D.R. (1984) Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. J. Clin. Endocrinol. Metabol., 58, 850-856.
11. Dalton, M.B., Fantle, K.S., Bechtold, H.A., DeMaio, L., Evans, R.,M., Krystosek, A. and Sinensky, M. (1995) The farnesylation protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization. Cancer Res., 55, 3295-3304.
12. Danesi, R., Nardini, D., Basolo, F., Del Tacca, M., Samid, D. and Myers, C.E. (1996) Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-Ras oncogene. Mol. Pharmacol., 49, 972-979.
13. DeClue, J.E., Vass, W.C., Papageorge, A.G., Lowy, D.R. and Willumsen, B.M. (1991) Inhibition of cell growth by lovastatin is independent of ras function. Cancer Res., 51, 712-717.
14. Endo, A. (1985) Specific non-sterol inhibitors of HMG-CoA reductase. In Preiss, B. (ed.), Regulation of HMG-CoA reductase. New York, Academic Press, pp. 49-78.
15. Gammeltoft, S. (1990) Peptide hormone receptors. In Siddle, K. and Hutton, J.C. (eds.), Peptide hormone action. A practical approach. Oxford, Oxford University Press, pp. 1-41.
16. Goldstein, J.L., and Brown, M.S. (1990) Regulation of the mevalonate pathway. Nature, 343, 425-430.
17. Habenicht, A.J.R., Glomset, J.A. and Ross, R. (1980) Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem., 255, 5134-5140.
18. Hancock, J.F., Magee, A.I., Childs, J.E. and Marshall, C.J. (1989) All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57, 1167-1177.
19. Hart, G.W. (1992) Glycosylation. Curr. Opin. Cell Biol., 4, 1017-1023.
20. Heifetz, A., Keenan, R.W. and Elbein, A.D. (1979) Mechanism of action of tunicamycin on the UDP-GlcNAc: dolichyl-phosphate GlcNAc-1-phosphate transferase. Biochemistry, 18, 2186-2192.
21. Hirschberg, C.B. and Snider, M.D. (1987) Topography of glycosylation in the rough endoplasmic reticulum and Golgi apparatus. Annu. Rev. Biochem., 56, 63-87.
22. Hsu, S.M., Raine, L. and Fanger, H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580.
23. James, G.L., Brown, M.S., Cobb, M.H. and Goldstein, J.L. (1994) Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells. J. Biol. Chem., 269, 27705-27714.
24. Keating, M.T., Harryman, C.C. and Williams, L.T. (1989) Platelet-derived growth factor receptor inducibility is acquired immediately after translation and does not require glycosylation. J. Biol. Chem., 264, 9129-9132.
25. Kull, F.C., Jacobs, S., Su, Y.F., Svoboda, M.E., Van Wyk, J.J. and Cuatrecasas, P. (1983) Monoclonal antibodies to receptors for insulin and somatomedin-C. J. Biol. Chem., 258, 6561-6566.
26. Laemmli, U.K. (1970) Most commonly used discontinuous buffer systems for SDS electrophoresis. Nature, 227, 680-685.
27. Larsson, O. (1985) Commitment events in early G1 requirement for the synthesis of dolichol dependent glycoproteins. Cell Biol. Int. Rep., 9, 627-636.
28. Larsson, O. (1993) Cell-cycle-specific inhibition of human breast cancer cells induced by two metabolic inhibitors. Glycobiology, 3, 475-479.
29. Larsson, O. and Zetterberg, A. (1986) Effects of 25-hydroxycholesterol, cholesterol and isoprenoid derivatives on the G1-progression in Swiss 3T3 cells. J. Cell Physiol., 129, 94-102.
30. Lennon, K., Pretel, R., Kesselheim, J., te Heesen, S. and Kukuruzinska, M.A. (1995) Proliferation-dependent differential regulation of the dolichol pathway genes in Saccharomyces cerevisiae. Glycobiology, 5, 633-642.
31. Leonard, S., Beck, L. and Sinensky, M. (1990) Inhibition of isoprenoid biosynthesis and the post-translational modification of pro-p21ras. J. Biol. Chem., 265, 5157-5160.
32. Liu, D., Rutter, W.J. and Wang, L.-H. (1992) Enhancement of transforming potential and human insulin-like growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma URS gag sequence. J. Virol., 66, 374-385.
33. Maltese, W.A. and Sheridan, K.M. (1987) Isoprenylated protein in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J. Cell Physiol., 133, 471-481.
34. McCormick, F. (1994) Activators and effectors of ras p21 proteins. Curr. Opin. Genet. Dev., 4, 71-76.
35. Mota, O.M., Huang, G.T. and Kukuruzinska, M.A. (1994) Developmental regulation and tissue-specific expression of hamster dolichol-P-dependent N-acetylglucosamine-1-P transferase (GPT). Biochem. Biophys. Res. Commun., 204, 284-291.
36. Noonan, K.E., Beck, C., Holzmayer, T.A., Chin, J.E., Wunder, J.S., Andrulis, I.L., Gazdar, A.F., Willman, C.L., Griffith, B., Von Hoff, D.D. and Roninson, I.B. (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87, 7160-7164.
37. Paulsson, Y. Bywater, M., Heldin, C.H. and Westermark, B. (1987) Effects of epidermal growth factor and platelet-derived growth factor on c-fos and c-myc mRNA levels in normal human fibroblasts. Exp. Cell Res., 171, 186-194.
38. Pretel, R., Lennon, K., Bird, A. and Kukuruzinska, M.A. (1995) Expression of the first N-glycosylation gene in the dolichol pathway, ALG7, is regulated at two major control points in the G1 phase of the Saccharomyces cerevisiae cell cycle. Exp. Cell Res., 219, 477-486.
39. Rosenwald, A.G., Stoll, J. and Krag, S.S. (1990) Regulation of glycosylation. J. Biol. Chem., 265, 14544-14553.
40. Rubini, M., Werner, H., Gandini, E., Roberts, C.T., Jr., LeRoith, D. and Baserga, R. (1994) Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene. Exp. Cell Res., 211, 374-379.
41. Schafer, W.R., Kim, R., Sterne, R., Thorne, J., Kim, S.-H. and Rine, J. (1989) Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science, 245, 379-385.
42. Sheeler, P. (1981) Centrifugation in Biology and Medical Science. Wiley, New York.
43. Sinensky, M. and Lutz, R.J. (1992) The prenylation of proteins. BioEssays, 14, 25-31.
44. Vincent, T.S., Wülfert, E. and Merler, E. (1991) Inhibiton of growth factor signaling pathways by lovastatin. Biochem. Biophys. Res. Commun., 180, 1284-1289.